CABALETTA BIO INCORPORATED (CABA)

Earnings call transcript: Cavco Industries posts record revenue in Q1 2026

Vanguard Capital Management files Schedule 13G for Cabaletta Bio, reporting 8,295,783 shares, or 5.08% of common stock, with sole dispositive power over the entire position.

Meta (META) being coy about future AI spending isn't what the market wants to hear as overspending fears rattle tech stocks. Yet that's what the market got — and Meta received another earnings day stock plunge in return.

The company reported ($0.39) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.02. On average, analysts expect Cabaletta Bio to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year. Shares of CABA stock opened at $2.62 on Thursday.

Meta shares dropped after its earnings per share came in lighter than expected and revenue slightly beat estimates. Catch up on the analyst call.